| Michael Edward Fruth, RPH | |
|
2501 Jackson Ave, Point Pleasant, WV 25550-2035 | |
| (304) 675-2303 | |
| Not Available |
| Full Name | Michael Edward Fruth |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 2501 Jackson Ave, Point Pleasant, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821369927 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 03312056 (Ohio) | Secondary |
| 183500000X | Pharmacist | RP0003319 (West Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michael Edward Fruth, RPH 2501 Jackson Ave, Point Pleasant, WV 25550-2035 Ph: (304) 675-2303 | Michael Edward Fruth, RPH 2501 Jackson Ave, Point Pleasant, WV 25550-2035 Ph: (304) 675-2303 |
News Archive
"Lean Laboratory" is being implemented in many industries, with the aim of eliminating mistakes, reducing delays, lowering costs and improving the quality of a product or service.Visit METTLER TOLEDO's free online laboratory expertise library to learn more about what it is, the benefits of this approach, where to start with Lean Laboratory, and more.
In Montana's conservative Flathead County, prosecutors and local leaders were turning a blind eye to businesses that flouted state mask and social distancing mandates, even as the area's COVID infections climbed to their highest levels.
Endo Pharmaceuticals has submitted a complete response to the U.S. Food and Drug Administration (FDA) following the company's receipt of a Complete Response letter in October 2009 related to the New Drug Application (NDA) submission for FORTESTA™ (testosterone) 2% gel. The company's Class 2 resubmission is the next step in its intention to offer FORTESTA as a treatment option in the United States for men diagnosed with low testosterone (Low T), also known as hypogonadism. The FDA's review period for Class 2 resubmissions typically is six months.
University of Adelaide researchers have identified a likely molecular pathway that causes a group of untreatable neurodegenerative diseases, including Huntington's disease and Lou Gehrig's disease.
› Verified 9 days ago
John Michael Beaver Ii, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2520 Valley Dr, Point Pleasant, WV 25550 Phone: 304-674-2412 Fax: 304-675-7150 | |
Dr. Dakota Toth, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2501 Jackson Ave, Point Pleasant, WV 25550 Phone: 304-675-2303 | |
Jamie Bennett, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2501 Jackson Ave, Point Pleasant, WV 25550 Phone: 304-675-2303 | |
Dr. Michael Durst, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4016 Ohio River Rd, Point Pleasant, WV 25550 Phone: 304-675-1612 | |
Dr. Christopher Childress, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2501 Jackson Ave, Point Pleasant, WV 25550 Phone: 304-675-2303 | |
Rumsey Oates, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2501 Jackson Ave, Point Pleasant, WV 25550 Phone: 304-675-2303 Fax: 304-675-7762 | |
Gary Hatfield Ii, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4016 Ohio River Rd, Point Pleasant, WV 25550 Phone: 304-675-1612 |